According to our findings of the significant high expression of TAF1B in hepatocellular carcinoma tissues and its poor prognosis, we conclude that targeting TAF1B may give another method of treating malignancies by interfering with the transcriptional activity of Pol I. Here, TAF1B is linked to hepatocellular carcinoma.